GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,485.60p
   
  • Change Today:
      24.60p
  • 52 Week High: 2,263.00p
  • 52 Week Low: 1,296.00p
  • Currency: UK Pounds
  • Shares Issued: 4,094.68m
  • Volume: 7,774,368
  • Market Cap: £60,831m
  • RiskGrade: 129

Latest ShareCast News

FDA approves GSK anaemia drug

By Abigail Townsend

Date: Thursday 02 Feb 2023

(Sharecast News) - The US regulator has given the green light to a GSK treatment for anaemia in patients with chronic kidney disease, the medicines and vaccines group confirmed on Thursday.

GSK ShareCast News

Record vaccine sales boost profits at GSK 01-Feb-2023 ShareCast
GSK plans return of HQ to central London in 2024 12-Dec-2022 ShareCast
GSK shares jump as court dismisses Zantac claims 07-Dec-2022 ShareCast
EU validates market application for GSK blood ca... 02-Dec-2022 ShareCast
GSK cancer treatment meets trial endpoint 02-Dec-2022 ShareCast

GSK Regulatory News

Daprodustat approved by US FDA for anaemia of CKD 02-Feb-2023 07:00 RNS
Director/PDMR Shareholding 01-Feb-2023 15:30 RNS
Total Voting Rights 01-Feb-2023 15:00 RNS
Benlysta granted Orphan Drug Designation by US FDA 01-Feb-2023 07:05 RNS
Final Results 01-Feb-2023 07:00 RNS

GSK Newspaper Links

Life sciences at tipping point, warns GSK boss D... 02-Feb-2023 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,485.60p
Change Today 24.60p
% Change 1.68 %
52 Week High 2,263.00p
52 Week Low 1,296.00p
Volume 7,774,368
Shares Issued 4,094.68m
Market Cap £60,831m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.29% below the market average58.29% below the market average58.29% below the market average58.29% below the market average58.29% below the market average
82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average
Price Trend
40.31% below the market average40.31% below the market average40.31% below the market average40.31% below the market average40.31% below the market average
25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average
Income
67.69% above the market average67.69% above the market average67.69% above the market average67.69% above the market average67.69% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
51.89% below the market average51.89% below the market average51.89% below the market average51.89% below the market average51.89% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 14
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 07-Feb-2023

Time Volume / Share Price
16:45 153 @ 1,485.40p
16:45 153 @ 1,485.40p
16:45 6,466 @ 1,485.40p
16:45 6,466 @ 1,485.40p
16:35 1,000 @ 1,485.60p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page